ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,051Medicare Part D Prescriptions Filled, Including Refills

Rank: 110 out of 2604

$658K Total Retail Price of All Prescriptions

Rank: 93 out of 2604

343 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 343 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

28% of this provider’s 343 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 6,340 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 496 290 1 4
HYDROCODONE-ACETAMINOPHEN 388 211 S3 2 1
POTASSIUM CHLORIDE 238 186 3 16
LISINOPRIL 236 172 4 3
FUROSEMIDE 230 153 5 8
OMEPRAZOLE 214 159 6 5
METOPROLOL TARTRATE 195 138 7 9
SIMVASTATIN 195 114 7 2
CITALOPRAM HBR 159 97 9 18
RISPERIDONE 156 111 10 65
POLYETHYLENE GLYCOL 3350 139 104 11 42
CEFPROZIL 124 89 12 303
DONEPEZIL HCL 122 115 13 28
NAMENDA 120 111 14 37
AMLODIPINE BESYLATE 112 89 15 6
PRAVASTATIN SODIUM 110 62 16 14
RANITIDINE HCL 109 65 17 25
LYRICA 108 44 18 79
GABAPENTIN 108 55 18 12
WARFARIN SODIUM 108 80 18 13
SERTRALINE HCL 106 88 21 23
DIVALPROEX SODIUM 93 67 22 81
FAMOTIDINE 92 57 23 68
ATENOLOL 92 30 23 11
TOPIRAMATE 90 11 25 143
CYMBALTA 89 42 26 44
ZOLPIDEM TARTRATE 88 47 27 21
MELOXICAM 86 54 28 36
BENZTROPINE MESYLATE 85 53 R 29 189
CLOPIDOGREL 84 67 30 39
LANTUS 81 32 31 40
METFORMIN HCL 77 44 32 7
ALENDRONATE SODIUM 76 61 33 29
QUETIAPINE FUMARATE 76 62 33 66
LEVETIRACETAM 75 34 35 96
METOPROLOL SUCCINATE 75 58 35 17
FLUCONAZOLE 75 53 35 160
LIOTHYRONINE SODIUM 74 47 38 264
BUMETANIDE 73 72 39 70
FLUOXETINE HCL 73 44 39 49
NEXIUM 69 41 41 53
CARVEDILOL 68 56 42 26
HYDROCHLOROTHIAZIDE 68 50 42 10
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 53 42 91
LOVASTATIN 67 45 45 24
ABILIFY 64 41 46 130
CARBIDOPA-LEVODOPA 63 50 47 97
OLANZAPINE 62 37 48 115
NYSTOP 60 50 49 163
BACLOFEN 54 25 50 101
DOXYCYCLINE HYCLATE 54 40 50 122
FENTANYL 52 19 S2 52 48
NAPROXEN 51 29 53 76
ENALAPRIL MALEATE 51 45 53 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 4, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.